18 episodes

Welcome to ASRS’s Journal of Vitreoretinal Diseases (JVRD) Author’s Forum. JVRD is the official scientific peer-reviewed journal of the American Society of Retina Specialists (ASRS) offering the highest quality and most impactful research and clinical information in the field. Join host Dr. Timothy Murray, Editor-in-Chief for JVRD as he discusses cutting-edge developments featured in JVRD with the lead authors who share clinical pearls and explore their significance for advancing patient care. Audio episodes are available on Amazon Music, Apple Podcasts, Google Podcasts, Spotify and other podcast directories. Or visit our YouTube channel to watch the dynamic conversation in each episode.

ASRS’s Journal of Vitreoretinal Diseases (JVRD) Author’s Forum American Society of Retina Specialists (ASRS)

    • Health & Fitness

Welcome to ASRS’s Journal of Vitreoretinal Diseases (JVRD) Author’s Forum. JVRD is the official scientific peer-reviewed journal of the American Society of Retina Specialists (ASRS) offering the highest quality and most impactful research and clinical information in the field. Join host Dr. Timothy Murray, Editor-in-Chief for JVRD as he discusses cutting-edge developments featured in JVRD with the lead authors who share clinical pearls and explore their significance for advancing patient care. Audio episodes are available on Amazon Music, Apple Podcasts, Google Podcasts, Spotify and other podcast directories. Or visit our YouTube channel to watch the dynamic conversation in each episode.

    Gene Expression Profile Class Change in a Case of Aggressive, Recurrent Melanoma

    Gene Expression Profile Class Change in a Case of Aggressive, Recurrent Melanoma

    In this episode, Dr. Timothy Murray joins Dr. Jennifer Aye to talk about a case of recurrent aggressive ciliochoroidal melanoma requiring enucleation after brachytherapy elsewhere for recurrence at the biopsy site. The tumor showed progression from gene expression profiling (GEP) class 1A, PRAME negative to GEP Class 1b.
     For more information visit www.ASRS.org/JVRDForum.

    Welcome to ASRS’s Journal of Vitreoretinal Diseases (JVRD) Author’s Forum. JVRD is the official scientific peer-reviewed journal of the American Society of Retina Specialists (ASRS) offering the highest quality and most impactful research and clinical information in the field. Join host Dr. Timothy Murray, Editor-in-Chief for JVRD as he discusses cutting-edge developments featured in JVRD with the lead authors who share clinical pearls and explore their significance for advancing patient care. 

    Audio episodes are available on Amazon Music, Apple Podcasts, Google Podcasts, Spotify and other podcast directories.

    • 12 min
    Chronic Effects of e-Cigarette Aerosol Inhalation on Macular Perfusion

    Chronic Effects of e-Cigarette Aerosol Inhalation on Macular Perfusion

    In this episode, Dr. Timothy Murray joins Dr. Lejla Vajzovic to discuss the impact of e-cigarette use on macular perfusion employing optical coherence tomography angiography (OCTA) in a study of 25 patients.  Learn if there are differences in retinal microvasculature measurements in patients using e-cigarettes compared to nonsmoker control groups.

    For more information visit www.ASRS.org/JVRDForum.

    Welcome to ASRS’s Journal of Vitreoretinal Diseases (JVRD) Author’s Forum. JVRD is the official scientific peer-reviewed journal of the American Society of Retina Specialists (ASRS) offering the highest quality and most impactful research and clinical information in the field. Join host Dr. Timothy Murray, Editor-in-Chief for JVRD as he discusses cutting-edge developments featured in JVRD with the lead authors who share clinical pearls and explore their significance for advancing patient care. 

    Audio episodes are available on Amazon Music, Apple Podcasts, Google Podcasts, Spotify, and other podcast directories.
     

    • 12 min
    Retinopathy Associated With Ritonavir Treatment for HIV Infection: A Case Series Reappraisal in the COVID-19 Era

    Retinopathy Associated With Ritonavir Treatment for HIV Infection: A Case Series Reappraisal in the COVID-19 Era

    In this episode, Dr. Timothy Murray welcomes Steven Yeh, MD, University of Nebraska Medical Center, Truhlsen Eye Institute to discuss 3 cases of retinopathy secondary to ritonavir use in the treatment of HIV.  The review identified 3 patients with a history of HIV treated with antiretroviral therapy including ritonavir who had been evaluated for bilateral vision loss in both eyes.  Explore why ritonavir toxicity should be considered in the differential diagnosis of retinopathy among patients with an exposure history.

    For more information visit www.ASRS.org/JVRDForum.

    Welcome to ASRS’s Journal of Vitreoretinal Diseases (JVRD) Author’s Forum. JVRD is the official scientific peer-reviewed journal of the American Society of Retina Specialists (ASRS) offering the highest quality and most impactful research and clinical information in the field. Join host Dr. Timothy Murray, Editor-in-Chief for JVRD as he discusses cutting-edge developments featured in JVRD with the lead authors who share clinical pearls and explore their significance for advancing patient care. 

    Audio episodes are available on Amazon Music, Apple Podcasts, Google Podcasts, Spotify, and other podcast directories.

    • 13 min
    Retinal Vasculitis After Intravitreal Pegcetacoplan: Report From the ASRS ReST Committee

    Retinal Vasculitis After Intravitreal Pegcetacoplan: Report From the ASRS ReST Committee

    On this episode, Dr. Murray welcomes Andre Witkin, MD, Associate Professor, Tufts University School of Medicine, Boston, MA, to discuss the article, Retinal Vasculitis After Intravitreal Pegcetacoplan: Report From the ASRS Research and Safety in Therapeutics (ReST) Committee.
    On February 17, 2023, pegcetacoplan 15mg (Syfovre – Apellis Pharmaceuticals, Waltham MA) was approved by the US Food and Drug Administration (FDA) to treat geographic atrophy (GA) secondary to age-related macular degeneration (AMD). Beginning in April 2023, the American Society of Retina Specialists (ASRS) Research and Safety in Therapeutics (ReST) Committee began receiving reports of intraocular inflammation (IOI) following intravitreal pegcetacoplan administration. In addition to cases of IOI without retinal vascular involvement, several reported cases included retinal vasculitis resulting in occlusive retinal vasculopathy and significant vision loss. The American Society of Retina Specialists (ASRS) Research and Safety in Therapeutics (ReST) Committee, as well as an expert panel, performed a retrospective review of cases of retinal vasculitis reported to the ASRS. Clinical and imaging characteristics were reviewed for evidence of retinal vasculitis and analyzed.

    For more information visit www.ASRS.org/JVRDForum.

    Welcome to ASRS’s Journal of Vitreoretinal Diseases (JVRD) Author’s Forum. JVRD is the official scientific peer-reviewed journal of the American Society of Retina Specialists (ASRS) offering the highest quality and most impactful research and clinical information in the field. Join host Dr. Timothy Murray, Editor-in-Chief for JVRD as he discusses cutting-edge developments featured in JVRD with the lead authors who share clinical pearls and explore their significance for advancing patient care. 

    Audio episodes are available on Amazon Music, Apple Podcasts, Google Podcasts, Spotify and other podcast directories.

    • 15 min
    Retina Controversy: Biosimilar to Biosimilar Anti-VEGF Switching for Retinal Diseases

    Retina Controversy: Biosimilar to Biosimilar Anti-VEGF Switching for Retinal Diseases

    On this episode, Dr. Timothy Murray welcomes Dr. Baruch Kuppermann, Gavin Herbert Eye Institute, University of California, Irvine, California, to explore evidence from other specialties regarding cross-switching between biosimilars, and learn if there are any foreseen patient safety concerns for retina specialists.

    For more information visit www.ASRS.org/JVRDForum.

    Welcome to ASRS’s Journal of Vitreoretinal Diseases (JVRD) Author’s Forum. JVRD is the official scientific peer-reviewed journal of the American Society of Retina Specialists (ASRS) offering the highest quality and most impactful research and clinical information in the field. Join host Dr. Timothy Murray, Editor-in-Chief for JVRD as he discusses cutting-edge developments featured in JVRD with the lead authors who share clinical pearls and explore their significance for advancing patient care. 

    Audio episodes are available on Amazon Music, Apple Podcasts, Google Podcasts, Spotify and other podcast directories.
    Explore the podcast

    • 15 min
    Effect of Prefilled vs Vial-Drawn Syringes on Sustained Increases in lOP in Pts Treated With Aflibercept

    Effect of Prefilled vs Vial-Drawn Syringes on Sustained Increases in lOP in Pts Treated With Aflibercept

    On this episode, Dr. Timothy Murray welcomes Aleksandra Rachitskaya, MD, FASRS, of Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio to explore the effect of syringe type on developing sustained intraocular pressure (IOP) increases.  Learn how the type of syringe may or may not affect outcomes.

    For more information visit www.ASRS.org/JVRDForum.

    Welcome to ASRS’s Journal of Vitreoretinal Diseases (JVRD) Author’s Forum.  JVRD is the official scientific peer-reviewed journal of the American Society of Retina Specialists (ASRS) offering the highest quality and most impactful research and clinical information in the field. Join host Dr. Timothy Murray, Editor-in-Chief for JVRD as he discusses cutting-edge developments featured in JVRD with the lead authors who share clinical pearls and explore their significance for advancing patient care. Audio episodes are available on Amazon Music, Apple Podcasts, Google Podcasts, Spotify and other podcast directories.

    • 17 min

Top Podcasts In Health & Fitness

The School of Greatness
Lewis Howes
Huberman Lab
Scicomm Media
Soothing Sleep
OpenMind
ZOE Science & Nutrition
ZOE
Passion Struck with John R. Miles
John R. Miles
The Doctor's Farmacy with Mark Hyman, M.D.
Dr. Mark Hyman